Conmed (CNMD) Tops Q1 EPS by 8c; Hikes FY22 Revenue Guidance
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $49.82 +0.69%
Financial Fact:
Provision for income taxes: 2.65M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Provision for income taxes: 2.65M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Conmed (NYSE: CNMD) reported Q1 EPS of $0.70, $0.08 better than the analyst estimate of $0.62. Revenue for the quarter came in at $242.3 million versus the consensus estimate of $235.77 million.
GUIDANCE:
Conmed sees FY2022 revenue of $1.105-1.15 billion, versus the consensus of $1.09 billion.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Lument Finance Trust (LFT) Misses Q2 EPS by 17c
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
